Ignite Creation Date:
2025-12-25 @ 4:19 AM
Ignite Modification Date:
2026-05-03 @ 1:49 PM
Study NCT ID:
NCT04675320
Status:
UNKNOWN
Last Update Posted:
2023-12-07
First Post:
2020-12-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors
Sponsor:
Centre Georges Francois Leclerc
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2020-A00036-33
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None